Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure

Archives of Cardiovascular Diseases

Volumn 102, Issue 3, 2009, Pages 169-175

  Paulino, Alexandra ^a   Damy, Thibaud ^a,b,c   Margarit, Laurent ^a   Stoïca, Maria ^a   Deswartea, Guillaume ^a   Khouri, Latifa ^a   Vermes, Emmanuelle ^a   Meizels, Anouk ^a   Hittinger, Luc ^a,b,c   D'Ortho, Marie Pia ^a,b,d  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Congestive heart failure; Prevalence; Sleep apnoea syndromes

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICHANNEL RECORDER; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

EID: 67349148105     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.12.006     Document Type: Article

References (26)

1. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-9.
2. Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9:251-7.
3. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-31.
4. Javaheri S, Shukla R, Zeigler H, et al. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028-34.
5. Arzt M, Floras JS, Logan AG, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173-80.
6. Philippe C, Stoica-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006;92:337-42.
7. Tremel F, Pepin JL, Veale D, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999;20:1201-9.
8. Garrigue S, Pepin JL, Defaye P, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007;115:1703-9.
9. Zhao ZH, Sullivan C, Liu ZH, et al. Prevalence and clinical characteristics of sleep apnea in Chinese patients with heart failure. Int J Cardiol 2007;118:122-3.
10. Schulz R, Blau A, Borgel J, et al. Sleep apnoea in heart failure. Eur Respir J 2007;29:1201-5.
11. MacDonald M, Fang J, Pittman SD, et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med 2008;4:38-42.
12. Vazir A, Hastings PC, Dayer M, et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007;9:243-50.
13. Rao A, Georgiadou P, Francis DP, et al. Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res 2006;15:81-8.
14. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006;106:21-8.
15. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101-6.
16. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499-521.
17. Vazir A, Hastings PC, Papaioannou I, et al. Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure. Respir Med 2008;102:831-9.
18. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
19. Kohnlein T, Welte T. Does beta-blocker treatment influence central sleep apnoea? Respir Med 2007;101:850-3.
20. Tamura A, Kawano Y, Naono S, et al. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130-5.
21. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
22. Hume KI, Van F, Watson A. A field study of age and gender differences in habitual adult sleep. J Sleep Res 1998;7:85-94.
23. Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 1998;84:1055-62.
24. Popovic RM, White DP. Influence of gender on waking genioglossal electromyogram and upper airway resistance. Am J Respir Crit Care Med 1995;152:725-31.
25. Dancey DR, Hanly P, Soong C, et al. Impact of menopause on the prevalence and severity of sleep apnea. Chest 2001;120:151-5.
26. Allam JS, Olson EJ, Gay PC, et al. Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 2007;132:1839-46.